American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 212-223, February 2008

The Relationship Between Nontraditional Risk Factors and Outcomes in Individuals With Stage 3 to 4 CKD

  • Daniel E. Weiner, MD, MS

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Daniel E. Weiner, MD, MS, Division of Nephrology, Box #391, Tufts-New England Medical Center, Boston, MA 02111.
  • ,
  • Hocine Tighiouart, MS

      Affiliations

    • Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA
  • ,
  • Essam F. Elsayed, MD

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA
  • ,
  • John L. Griffith, PhD

      Affiliations

    • Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA
  • ,
  • Deeb N. Salem, MD

      Affiliations

    • Division of Cardiology, Tufts-New England Medical Center, Boston, MA.
  • ,
  • Andrew S. Levey, MD

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA
  • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Division of Nephrology, Tufts-New England Medical Center, Boston, MA

Received 9 July 2007; accepted 16 October 2007. published online 03 January 2008.

Background

Chronic kidney disease is associated with increased risk for cardiovascular disease and mortality. Both traditional and nontraditional cardiovascular disease risk factors may contribute.

Study Design

Cohort.

Settings & Participants

Community-based adult population of the Atherosclerosis Risk in Communities and Cardiovascular Health Studies with estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2.

Predictors

Nontraditional cardiovascular disease risk factors, including body mass index, diastolic blood pressure, and triglyceride, albumin, uric acid, fibrinogen, C-reactive protein, and hemoglobin levels.

Outcomes

Composite of myocardial infarction, stroke, and all-cause mortality. Secondary outcomes included individual components of the composite.

Results

Of 1,678 individuals with decreased eGFR (mean, 51.1 ± 8.5 mL/min/1.73 m2), 891 (53%) reached the composite end point during a median follow-up of 108 months; 23% had a cardiac event, 45% died, and 14% experienced a stroke. Serum albumin level less than 3.9 g/dL (hazard ratio, 0.68 for every 0.3-g/dL decrease; 95% confidence interval, 0.60 to 0.77), increased serum triglyceride level (hazard ratio, 1.07 for every 50-mg/dL increase; 95% confidence interval, 1.02 to 1.12), C-reactive protein level (hazard ratio, 1.15 per log-unit increase; 95% confidence interval, 1.07 to 1.24), and fibrinogen level (hazard ratio, 1.12 per 50-mg/dL increase; 95% confidence interval, 1.07 to 1.18) independently predicted composite events. Both decreased (<14.5 g/dL) and increased (>14.5 g/dL) hemoglobin levels predicted composite events. Serum albumin level less than 3.9 g/dL and increased serum fibrinogen level independently predicted cardiac events. For serum albumin and hemoglobin levels, the relationship with composite and mortality outcomes was nonlinear (P < 0.001).

Limitations

Single assessment of eGFR. No albuminuria data.

Conclusions

Several nontraditional cardiovascular disease risk factors predict adverse outcomes in individuals with stage 3 to 4 chronic kidney disease. The relationship between risk factors and outcomes is often nonlinear.

Index Words: Chronic kidney disease, cardiovascular disease, risk factors, inflammation, cholesterol

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2007.10.035 on December 28, 2007.

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Peter A. McCullough, MD, MPH, William Beaumont Hospital) who served as Acting Editor-in-Chief. Details of the journal’s procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(07)01479-5

doi:10.1053/j.ajkd.2007.10.035

American Journal of Kidney Diseases
Volume 51, Issue 2 , Pages 212-223, February 2008